This Institution Assumes Strategic Planning As A Tool Of The National Planning And Public Investment System, With The Purpose Of Aligning National And International Commitments In A Unique And Coherent Framework That Allows Progress In The Achievement Of The Different Objectives And Ensures The Reduction Of Demand And Control Of Drug Supply By Obtaining The Institutional Results That Respond To The Results Of Government And In Turn, To The Policies Of The State. Given The Dynamic And Complex Nature Of The Drug Phenomenon That Has Once Again Become Evident In The Context Of The Covid-19 Pandemic; The Institutional Strategy 2021-2024 Adopts A Future-Oriented Approach To Change To Guarantee A Safe Response To The New Challenges. In That Sense, The Institutional Strategic Plan Includes Four (4) Specific Guidelines, Detailed Below: • Institutional Strengthening: Try To Apply A Model Of Comprehensive And Quality Management To Guarantee The Efficiency In The Development Of Drug Policies And Thus Overcome The Weaknesses Of Inter -Institutional Coordination Of Territorial And Sectoral Groups Taking Advantage Of The Conditions And Provisions Of All Actors Of Society. • Demand Reduction: Seeks To Avoid And Prevent Drug Use, As Well As Address The Negative Consequences For Both Health And Society Originated By The Improper Use Of Drugs, Through The Formulation, Articulation, Implementation And Monitoring Of Public Drug Policies In The Educational, Community, Labor, Sports And Policies Of Treatment, Rehabilitation And Social Reintegration. • Research: Refers To The Availability Of Updated And Reliable Information To Provide Users With Useful Information With Quality And Veracity, Both For Citizens In General And For Public And Private Institutions, Educational And Research Centers. • International Relations: Strengthening And Improving The Relationship With International Cooperation Mechanisms Of Which The Country Is Signatory, With The Purpose Of Promoting Good Drug Pract

Consejo Nacional de Drogas Dominican Republic has Released a tender for This Institution Assumes Strategic Planning As A Tool Of The National Planning And Public Investment System, With The Purpose Of Aligning National And International Commitments In A Unique And Coherent Framework That Allows Progress In The Achievement Of The Different Objectives And Ensures The Reduction Of Demand And Control Of Drug Supply By Obtaining The Institutional Results That Respond To The Results Of Government And In Turn, To The Policies Of The State. Given The Dynamic And Complex Nature Of The Drug Phenomenon That Has Once Again Become Evident In The Context Of The Covid-19 Pandemic; The Institutional Strategy 2021-2024 Adopts A Future-Oriented Approach To Change To Guarantee A Safe Response To The New Challenges. In That Sense, The Institutional Strategic Plan Includes Four (4) Specific Guidelines, Detailed Below: • Institutional Strengthening: Try To Apply A Model Of Comprehensive And Quality Management To Guarantee The Efficiency In The Development Of Drug Policies And Thus Overcome The Weaknesses Of Inter -Institutional Coordination Of Territorial And Sectoral Groups Taking Advantage Of The Conditions And Provisions Of All Actors Of Society. • Demand Reduction: Seeks To Avoid And Prevent Drug Use, As Well As Address The Negative Consequences For Both Health And Society Originated By The Improper Use Of Drugs, Through The Formulation, Articulation, Implementation And Monitoring Of Public Drug Policies In The Educational, Community, Labor, Sports And Policies Of Treatment, Rehabilitation And Social Reintegration. • Research: Refers To The Availability Of Updated And Reliable Information To Provide Users With Useful Information With Quality And Veracity, Both For Citizens In General And For Public And Private Institutions, Educational And Research Centers. • International Relations: Strengthening And Improving The Relationship With International Cooperation Mechanisms Of Which The Country Is Signatory, With The Purpose Of Promoting Good Drug Pract in . The tender was released on Mar 21, 2025.

Country - Dominican Republic

Summary - This Institution Assumes Strategic Planning As A Tool Of The National Planning And Public Investment System, With The Purpose Of Aligning National And International Commitments In A Unique And Coherent Framework That Allows Progress In The Achievement Of The Different Objectives And Ensures The Reduction Of Demand And Control Of Drug Supply By Obtaining The Institutional Results That Respond To The Results Of Government And In Turn, To The Policies Of The State. Given The Dynamic And Complex Nature Of The Drug Phenomenon That Has Once Again Become Evident In The Context Of The Covid-19 Pandemic; The Institutional Strategy 2021-2024 Adopts A Future-Oriented Approach To Change To Guarantee A Safe Response To The New Challenges. In That Sense, The Institutional Strategic Plan Includes Four (4) Specific Guidelines, Detailed Below: • Institutional Strengthening: Try To Apply A Model Of Comprehensive And Quality Management To Guarantee The Efficiency In The Development Of Drug Policies And Thus Overcome The Weaknesses Of Inter -Institutional Coordination Of Territorial And Sectoral Groups Taking Advantage Of The Conditions And Provisions Of All Actors Of Society. • Demand Reduction: Seeks To Avoid And Prevent Drug Use, As Well As Address The Negative Consequences For Both Health And Society Originated By The Improper Use Of Drugs, Through The Formulation, Articulation, Implementation And Monitoring Of Public Drug Policies In The Educational, Community, Labor, Sports And Policies Of Treatment, Rehabilitation And Social Reintegration. • Research: Refers To The Availability Of Updated And Reliable Information To Provide Users With Useful Information With Quality And Veracity, Both For Citizens In General And For Public And Private Institutions, Educational And Research Centers. • International Relations: Strengthening And Improving The Relationship With International Cooperation Mechanisms Of Which The Country Is Signatory, With The Purpose Of Promoting Good Drug Pract

Deadline - Mar 20, 2026

MT reference number - 105419622

Product classification - Architectural, construction, engineering and inspection services